著者

中川 直人 村井 ユリ子 小原 拓 大原 宏司 栗田 幸代 Lai Leanne

出版者

Japanese Society of Drug Informatics

雑誌

医薬品情報学 (ISSN:13451464)

巻号頁・発行日

vol.19, no.4, pp.180-187, 2018 (Released:2018-03-21)

参考文献数

9

被引用文献数

1

---

Objective: The clinical literature review is an important and required components in most of the US pharmacy school curriculum.  On the other hand, in Japan, pharmacy students usually read basic literature when research assignments are given.  However, in Japan, one is rarely taught how to critically read clinical literature in class.  Therefore, for the purpose of examining whether or not lectures regarding how to critically read clinical literature will affect collecting new drug information in pharmacy practice, we examined a survey which we circulated in both countries.  The survey asks pharmacists about reading clinical literature.Methods: One thousand nine hundred and ninety-seven pharmacists in Miyagi in Japan were given questionnaires by mail and 18,744 pharmacists in Florida in the US were given the URL of a web questionnaire by email.Results: Response rates in Miyagi and Florida were 30.3% and 0.91%, respectively.  Since the response in Florida was so small, statistical analysis was not performed.  Regarding the question of “Do you HABITUALLY read clinical literature ?,” “Yes” in Miyagi and Florida was 14.7% and 71.9%, respectively.  Regarding the question of “To what extent did you learn how to critically read clinical literature when you were a student-pharmacist ? ” (1: Not at all, 7: Yes), medians in Miyagi and Florida were “1” and “5,” respectively.  Regarding the question of “To what extent do you apply the information you obtain from clinical literature to your daily responsibilities ? ” (1: Not at all, 7: Yes), medians in Miyagi and Florida were “2” and “5,” respectively.Conclusions: We conclude that Japanese pharmacists in clinical practice do not sufficiently utilize drug information from new clinical literature because pharmacy education in Japan did not, until very recently at least, teach how to critically read clinical literature in class.

著者

石井 勇太 中川 直人 小原 拓 大原 宏司 栗田 幸代 村井 ユリ子

出版者

公益社団法人 日本薬学会

雑誌

YAKUGAKU ZASSHI (ISSN:00316903)

巻号頁・発行日

vol.140, no.9, pp.1195-1198, 2020-09-01 (Released:2020-09-01)

参考文献数

10

被引用文献数

2

---

The purpose of this study is to understand the reading habits of Japanese pharmacists regarding clinical trial literature in 2014. Questionnaires were mailed to 1997 pharmacists in Miyagi Prefecture. Six hundreds and five [342 (56.5%) hospital pharmacists and 254 (42.0%) community pharmacists] responded to questionnaires (Response rate: 30.3%). Regarding the question, “Do you habitually read clinical trial literature?”, 19.5% of hospital and 8.3% community pharmacists responded “yes”, respectively, which showed both pharmacists are not habitual readers of clinical trial literature. That would be because they did not study critical reading of clinical trial literature at pharmacy schools as well as their work environments to access and retrieve clinical trial literature were limited.

著者

桐生 嘉浩 本間 直美 吉野 多栄子 村井 ユリ子 祖父江 展 佐藤 良智

出版者

一般社団法人日本医薬品情報学会

雑誌

医薬品情報学 (ISSN:13451464)

巻号頁・発行日

vol.19, no.1, pp.8-16, 2017-05-31 (Released:2017-06-16)

参考文献数

13

---

Objective: Numerous new drugs have been developed in recent years, making the available types of prescription drugs quite diverse, with increasingly more complex drug interactions.  From an operations support system perspective, hospitals that cannot incorporate a large-scale custom-order system because of financial or use-efficiency limitations have no choice but to rely on commercial products.  However, this leaves many problems unsolved, such as functional restrictions and limited specifications.  In this study, we used Microsoft®Visual Basic®for Application (VBA) to develop an economical drug discrimination system suited to our situation and equipped with original function from the perspective of clinical pharmacists.Design: System design and development.Methods: We prototyped the system in VBA and used Microsoft®Excel®to create Query Tables.  The utility of the new system was evaluated based on drug discrimination output and time required in each process.Results: The new system is capable of inter-database communication and automated data analysis and uses drop-down lists of pre-defined options for data input in many places.  Compared with the conventional method, the new system enabled us to significantly reduce the average time needed to input and confirm data by as much as 61.9%.  This indicates that the new system can considerably reduce the time required for completing time-intensive processes and is also useful in preparing highly precise drug discrimination reports.Conclusion: Based on the results obtained so far, the new, original system, developed with zero design or development costs, is more efficient and offers more reliable information in the clinical setting than the conventional system.  As a result, we are able to maintain operational quality and reduce the amount of time required for drug discrimination.

著者

村井 ユリ子 佐藤 真由美 山口 浩明 眞野 成康 後藤 順一 菱沼 隆則

出版者

一般社団法人 日本医療薬学会

雑誌

日本医療薬学会年会講演要旨集

巻号頁・発行日

vol.17, 2007

著者

鈴木 裕之 中村 達也 宮浦 誠治 猪岡 京子 八木 朋美 我妻 恭行 鈴木 常義 髙村 千津子 鈴木 幹子 村井 ユリ子 中村 仁

出版者

一般社団法人日本医療薬学会

雑誌

医療薬学 (ISSN:1346342X)

巻号頁・発行日

vol.44, no.10, pp.503-509, 2018-10-10 (Released:2019-10-10)

参考文献数

17

---

Panvitan® powder for prescription (PP) administrated in combination with pemetrexed sodium hydrate (PEM) for the purposes of folic acid supplementation is significantly degraded by exposure to humidity or light. Hence, we investigated the influence of humidity and light on the color of the powder and concentration of folic acid in PP. We prepared samples by placing 1 g of PP into separate bags and stored them for 28 d under normal delivery conditions, intermediate humidity, high humidity, and light exposure. The amount of folic acid was quantified by high-performance liquid chromatography, where the percentage was calculated assuming the initial amount was 100%. Under normal delivery conditions (room temperature, 50% RH, shielded light) and intermediate humidity conditions (25℃, 75% RH, shielded light), no significant changes in appearance or folic acid content were observed. The sample stored under high humidity conditions (25℃, 91% RH, shielded light) changed in color from yellow to brown. The decrease in folic acid content was time dependent, and decreased to 47.1% after 28 d. Under light exposure (room temperature, 50% RH, 5,000 lux, 0.56 W/m2), the yellow color of PP becomes thin with time, while the folic acid content decreased to 73.2% after 28 d. The amount of folic acid may have decreased without any concomitant visible changes in the powder. The results of this study are expected to facilitate the management of adverse effects of PEM.

著者

橋本 貴尚 菊池 大輔 新沼 佑美 小原 拓 村井 ユリ子 畑中 貞雄 栃窪 克行 渡辺 善照

出版者

Japanese Society of Drug Informatics

雑誌

医薬品情報学 (ISSN:13451464)

巻号頁・発行日

vol.19, no.4, pp.158-171, 2018 (Released:2018-03-21)

参考文献数

15

---

Objective: To evaluate (1) a questionnaire for pharmacists on learning about drug information (DI) and using DI in practice, and (2) our DI seminar.Methods: (1) 72 hospitals and 105 community pharmacists in Miyagi, Japan were recruited.  The questionnaire included items on DI activities and questions about topics that pharmacists “want to study.”  (2) We held a seminar based on the questionnaire results and the reports of six pharmacists (one from a nonprofit corporation specializing in disseminating information on dietary supplements, one acute care pharmacist, two chronic and cancer hospital pharmacists, one community pharmacist, and one belonging to a community pharmacist association).  At the end of the seminar, participants were asked to complete an evaluation questionnaire on the seminar.Results: (1) The DI activity “participate in scientific meetings and collect information” was associated with other DI activities among both hospital and community pharmacists.  Multivariate analyses revealed that this DI activity was more strongly significantly associated with the topics “want to study techniques for presentation skills” (p<0.0001) and “want to study other DI practices” (p=0.008) than other DI activities.  (2) Sixty seven participants attended the seminar.  According to the evaluation questionnaire, the mean grade for the seminar was 80.5/100 points, and 96% of participants agreed with the “necessity of information sharing.”Conclusion: Participation in scientific meetings is important for pharmacists to develop their DI practice, and encourages information sharing between hospital and community pharmacists.  Environments in which more pharmacists have opportunities to participate in scientific meetings and related seminars are needed.